Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, EyePoint Pharmaceuticals Inc’s stock clocked out at $11.63, up 0.35% from its previous closing price of $11.59. In other words, the price has increased by $0.35 from its previous closing price. On the day, 0.54 million shares were traded. EYPT stock price reached its highest trading level at $11.77 during the session, while it also had its lowest trading level at $11.262.
Ratios:
To gain a deeper understanding of EYPT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.45 and its Current Ratio is at 5.50. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.10.
On August 28, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $15.
On January 22, 2024, JP Morgan started tracking the stock assigning a Overweight rating and target price of $35.JP Morgan initiated its Overweight rating on January 22, 2024, with a $35 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 23 ’24 when ANTHONY P. ADAMIS bought 67,100 shares for $10.04 per share.
David R. Guyer bought 36,975 shares of EYPT for $329,817 on Oct 14 ’24. On Aug 20 ’24, another insider, DICICCO WENDY F, who serves as the Director of the company, bought 2,567 shares for $7.79 each. As a result, the insider paid 19,997 and bolstered with 9,967 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EYPT now has a Market Capitalization of 793759168 and an Enterprise Value of 563076480. For the stock, the TTM Price-to-Sale (P/S) ratio is 17.40 while its Price-to-Book (P/B) ratio in mrq is 2.85. Its current Enterprise Value per Revenue stands at 12.318 whereas that against EBITDA is -4.914.
Stock Price History:
Over the past 52 weeks, EYPT has reached a high of $30.99, while it has fallen to a 52-week low of $5.86. The 50-Day Moving Average of the stock is 22.47%, while the 200-Day Moving Average is calculated to be -19.00%.
Shares Statistics:
It appears that EYPT traded 742.60K shares on average per day over the past three months and 1625700 shares per day over the past ten days. A total of 49.04M shares are outstanding, with a floating share count of 48.73M. Insiders hold about 7.56% of the company’s shares, while institutions hold 103.29% stake in the company. Shares short for EYPT as of 1728950400 were 9171397 with a Short Ratio of 12.35, compared to 1726185600 on 9101038. Therefore, it implies a Short% of Shares Outstanding of 9171397 and a Short% of Float of 20.09.
